REQUEST A DEMO
Total
USD $0.00
Search more companies

Astellas Pharma D.o.o. (Slovenia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Astellas Pharma D.o.o. Profile Updated: November 04, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Astellas Pharma D.o.o. is the Slovenian subsidiary of Astellas Pharma Inc., a global pharmaceutical company. The company is engaged in marketing, distribution and commercial activities for innovative prescription medicines and therapeutic solutions in areas such as oncology, immunology, nephrology, urology and other specialty therapeutic domains. Its business segments include regulatory compliance, market access, product marketing, sales force operations, pharmacovigilance and liaison with healthcare providers and institutions. Astellas Pharma D.o.o. sources products from the global Astellas portfolio and ensures their supply to the Slovenian healthcare market. The company's geographic focus is Slovenia, supported by connections to regional logistics and corporate governance structures. Strategic priorities include expanding patient access to innovative medicines, strengthening engagement with healthcare professionals, and supporting evidence-based medical practices in key therapeutic areas.

Headquarters
53 Shmartinska Road
Ljubljana; Osrednjeslovenska; Postal Code: 1000

Contact Details: Purchase the Astellas Pharma D.o.o. report to view the information.

Website: http://www.astellaspharma.si

Basic Information
Total Employees:
Purchase the Astellas Pharma D.o.o. report to view the information.
Registered Capital:
Purchase the Astellas Pharma D.o.o. report to view the information.
Financial Auditors:
Purchase the Astellas Pharma D.o.o. report to view the information.
Incorporation Date:
January 15, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Mednarodni Forum Znanstveno Raziskovalnih Farmacevtskih Druzb, Giz
Predstavnishtvo Astellas Pharma (Serbia)
Company Performance
Financial values in the chart are available after Astellas Pharma D.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
1.27%
Total operating revenue
1.27%
Operating profit (EBIT)
7.33%
EBITDA
2.4%
Net Profit (Loss) for the Period
-4.04%
Total Assets
14.52%
Total Equity
11.41%
Operating Profit Margin (ROS)
0.15%
Net Profit Margin
-0.08%
Return on Equity (ROE)
-1.65%
Debt/Equity
120.08%
Quick Ratio
-0.66%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?